Skip to main content
. 2021 Sep 3;12:705441. doi: 10.3389/fimmu.2021.705441

Figure 4.

Figure 4

Progression over time of positive detection of specific anti-Sars-Cov-2 antibodies using pooled results from 23 confirmed COVID-19 patients, including one IgG qualitative immunoassay (A) and two different IgG (B) and IgM (C) quantitative immunoassays, ANSH (Method 1) and AESKU (Method 2).